JP2012511917A - １型の血液細胞成分の同定のためのエピジェネティックマーカー - Google Patents
１型の血液細胞成分の同定のためのエピジェネティックマーカー Download PDFInfo
- Publication number
- JP2012511917A JP2012511917A JP2011541165A JP2011541165A JP2012511917A JP 2012511917 A JP2012511917 A JP 2012511917A JP 2011541165 A JP2011541165 A JP 2011541165A JP 2011541165 A JP2011541165 A JP 2011541165A JP 2012511917 A JP2012511917 A JP 2012511917A
- Authority
- JP
- Japan
- Prior art keywords
- lymphocytes
- seq
- amplification product
- methylation
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000601 blood cell Anatomy 0.000 title claims description 6
- 230000001973 epigenetic effect Effects 0.000 title description 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims abstract description 81
- 238000000034 method Methods 0.000 claims abstract description 65
- 238000004458 analytical method Methods 0.000 claims abstract description 42
- 230000011987 methylation Effects 0.000 claims abstract description 41
- 238000007069 methylation reaction Methods 0.000 claims abstract description 41
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 26
- 210000004369 blood Anatomy 0.000 claims abstract description 13
- 239000008280 blood Substances 0.000 claims abstract description 13
- 230000001105 regulatory effect Effects 0.000 claims abstract description 10
- 230000017858 demethylation Effects 0.000 claims abstract description 9
- 238000010520 demethylation reaction Methods 0.000 claims abstract description 9
- 238000001514 detection method Methods 0.000 claims abstract description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims abstract description 5
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 5
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 76
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 67
- 210000004027 cell Anatomy 0.000 claims description 49
- 230000003321 amplification Effects 0.000 claims description 47
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 47
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 30
- 241000124008 Mammalia Species 0.000 claims description 22
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 19
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 15
- 239000000523 sample Substances 0.000 claims description 12
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 11
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims description 9
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 9
- 102100039162 Adenine nucleotide translocase lysine N-methyltransferase Human genes 0.000 claims description 8
- 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 claims description 8
- 102100022086 GRB2-related adapter protein 2 Human genes 0.000 claims description 8
- 241000282414 Homo sapiens Species 0.000 claims description 8
- 101000889392 Homo sapiens Adenine nucleotide translocase lysine N-methyltransferase Proteins 0.000 claims description 8
- 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 claims description 8
- 101000900690 Homo sapiens GRB2-related adapter protein 2 Proteins 0.000 claims description 8
- 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 claims description 8
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 claims description 8
- 101000745163 Homo sapiens Neuronal acetylcholine receptor subunit alpha-3 Proteins 0.000 claims description 8
- 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 claims description 8
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 claims description 8
- 101000689224 Homo sapiens Src-like-adapter 2 Proteins 0.000 claims description 8
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 8
- 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 claims description 8
- 101000671855 Homo sapiens Ubiquitin-associated and SH3 domain-containing protein A Proteins 0.000 claims description 8
- 206010020751 Hypersensitivity Diseases 0.000 claims description 8
- 102100033016 Integrin beta-7 Human genes 0.000 claims description 8
- 102100033501 Interleukin-32 Human genes 0.000 claims description 8
- 102100039908 Neuronal acetylcholine receptor subunit alpha-3 Human genes 0.000 claims description 8
- 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 claims description 8
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 8
- 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 claims description 8
- 102100040337 Ubiquitin-associated and SH3 domain-containing protein A Human genes 0.000 claims description 8
- 102100038077 CD226 antigen Human genes 0.000 claims description 7
- 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 claims description 7
- 108020004414 DNA Proteins 0.000 claims description 7
- 101000884298 Homo sapiens CD226 antigen Proteins 0.000 claims description 7
- 101000887521 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 Proteins 0.000 claims description 7
- 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 claims description 7
- 101000620662 Homo sapiens Serine/threonine-protein phosphatase 6 catalytic subunit Proteins 0.000 claims description 7
- 101000800807 Homo sapiens Tumor necrosis factor alpha-induced protein 8 Proteins 0.000 claims description 7
- 101000606067 Homo sapiens Tyrosine-protein kinase TXK Proteins 0.000 claims description 7
- 101000818605 Homo sapiens Zinc finger and BTB domain-containing protein 32 Proteins 0.000 claims description 7
- 101000759545 Homo sapiens Zinc finger and BTB domain-containing protein 7B Proteins 0.000 claims description 7
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims description 7
- 102100022345 Serine/threonine-protein phosphatase 6 catalytic subunit Human genes 0.000 claims description 7
- 102100033649 Tumor necrosis factor alpha-induced protein 8 Human genes 0.000 claims description 7
- 102100039079 Tyrosine-protein kinase TXK Human genes 0.000 claims description 7
- 102100023265 Zinc finger and BTB domain-containing protein 7B Human genes 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 7
- 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 claims description 7
- 108091029523 CpG island Proteins 0.000 claims description 6
- 102100039844 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 Human genes 0.000 claims description 6
- 102100021135 Zinc finger and BTB domain-containing protein 32 Human genes 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 208000023275 Autoimmune disease Diseases 0.000 claims description 5
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 5
- 102100024510 Src-like-adapter 2 Human genes 0.000 claims description 5
- 206010052779 Transplant rejections Diseases 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 5
- 238000001369 bisulfite sequencing Methods 0.000 claims description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 210000004976 peripheral blood cell Anatomy 0.000 claims description 3
- 241000282693 Cercopithecidae Species 0.000 claims description 2
- 238000000018 DNA microarray Methods 0.000 claims description 2
- 241000700159 Rattus Species 0.000 claims description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 239000013068 control sample Substances 0.000 claims description 2
- 238000001976 enzyme digestion Methods 0.000 claims description 2
- 230000002068 genetic effect Effects 0.000 claims description 2
- 239000012620 biological material Substances 0.000 claims 1
- 230000007067 DNA methylation Effects 0.000 abstract description 10
- 210000003071 memory t lymphocyte Anatomy 0.000 abstract description 4
- 238000000275 quality assurance Methods 0.000 abstract description 4
- 238000003908 quality control method Methods 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract description 3
- 210000004296 naive t lymphocyte Anatomy 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract description 2
- 238000012163 sequencing technique Methods 0.000 description 9
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 7
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 239000003623 enhancer Substances 0.000 description 6
- 210000003289 regulatory T cell Anatomy 0.000 description 6
- 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 5
- 108091029430 CpG site Proteins 0.000 description 4
- 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 3
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 3
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 3
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 3
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 3
- 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 3
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 3
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 3
- 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 3
- 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 101100438932 Homo sapiens CD3D gene Proteins 0.000 description 2
- 101100112772 Homo sapiens CD3G gene Proteins 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 210000004970 cd4 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000004049 epigenetic modification Effects 0.000 description 2
- 230000006718 epigenetic regulation Effects 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000007124 immune defense Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000000207 lymphocyte subset Anatomy 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 101150060950 CD3D gene Proteins 0.000 description 1
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101150067056 Epsilon gene Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 1
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 101150034785 gamma gene Proteins 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000004034 genetic regulation Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002998 immunogenetic effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20080021838 EP2199411B1 (en) | 2008-12-16 | 2008-12-16 | Epigenetic markers for the identification of CD3 positive T-lymphocytes |
| EP08021838.1 | 2008-12-16 | ||
| PCT/EP2009/008764 WO2010069499A2 (en) | 2008-12-16 | 2009-12-08 | Epigenetic markers for the identification of blood sub-cells of type 1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012511917A true JP2012511917A (ja) | 2012-05-31 |
| JP2012511917A5 JP2012511917A5 (enExample) | 2012-12-20 |
Family
ID=40428037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011541165A Pending JP2012511917A (ja) | 2008-12-16 | 2009-12-08 | １型の血液細胞成分の同定のためのエピジェネティックマーカー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120107810A1 (enExample) |
| EP (2) | EP2199411B1 (enExample) |
| JP (1) | JP2012511917A (enExample) |
| CA (1) | CA2747312C (enExample) |
| DK (2) | DK2199411T3 (enExample) |
| ES (1) | ES2606350T3 (enExample) |
| PL (1) | PL2376648T3 (enExample) |
| WO (1) | WO2010069499A2 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016515397A (ja) * | 2013-04-19 | 2016-05-30 | エピオンティス ゲーエムベーハー | 生体サンプルにおける定量的細胞組成を特定する方法 |
| JP2020505938A (ja) * | 2017-02-09 | 2020-02-27 | エピオンティス ゲーエムベーハー | エピジェネティックな免疫細胞計数のための改善された方法 |
| JP2021502061A (ja) * | 2017-10-25 | 2021-01-28 | エピオンティス ゲーエムベーハー | 免疫細胞、特にｐｄ１＋ 細胞の同定のためのエピジェネティックマーカーとしてのｐｄｃｄ１ |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170233807A1 (en) | 2008-12-16 | 2017-08-17 | Epiontis Gmbh | Epigenetic Markers for the Identification of Blood Sub-cells of Type 1 |
| WO2012021867A2 (en) * | 2010-08-13 | 2012-02-16 | The Johns Hopkins University | A comprehensive methylome map of myeloid and lymphoid commitment from hematopoietic progenitors |
| WO2012045888A1 (en) | 2010-10-08 | 2012-04-12 | Epiontis Gmbh | Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes |
| US20130296328A1 (en) * | 2011-01-20 | 2013-11-07 | Université Libre de Bruxelles | Epigenetic portraits of human breast cancers |
| US20140178348A1 (en) | 2011-05-25 | 2014-06-26 | The Regents Of The University Of California | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
| EP2714933A4 (en) * | 2011-05-25 | 2014-12-31 | Univ Brown | METHODIZED METHOD FOR IDENTIFYING A CELL OR MIXING CELLS FOR THE PROGNOSIS AND DIAGNOSIS OF ILLNESSES AND FOR CELL HEALING THERAPIES |
| EP2788510B1 (en) | 2012-03-12 | 2016-12-14 | Epiontis GmbH | Epigenetic marker for the identification of cd3cd4 positive t lymphocytes |
| GB201221133D0 (en) | 2012-11-23 | 2013-01-09 | Epiontis Gmbh | Epigenetic method for the identification of subpopulations of CD8 and T lympocytes, in particular CD8 alpha and beta T lymphocytes |
| EP3382033B1 (en) * | 2017-03-30 | 2020-08-05 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Method for determining blood counts based on dna methylation |
| DE102018116353B4 (de) | 2018-07-05 | 2020-06-10 | Epiontis Gmbh | Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening |
| CN116949156B (zh) * | 2023-09-19 | 2023-12-08 | 美迪西普亚医药科技(上海)有限公司 | 一种基于核酸变体的通用型检测人t细胞的分析方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002171973A (ja) | 2000-12-07 | 2002-06-18 | Univ Tokyo | Ｄｎａメチル化パターンによる細胞の同定法 |
| AU2003285586A1 (en) | 2002-12-03 | 2004-06-23 | Medical Research Council | Regulatory t-cells |
| ATE508207T1 (de) | 2006-02-28 | 2011-05-15 | Charite Universitaetsmedizin | Nachweis und qualitätskontrolle von regulator-t- zellen mittels dna-methylierungsanalyse des foxp3-gens |
-
2008
- 2008-12-16 DK DK08021838.1T patent/DK2199411T3/en active
- 2008-12-16 EP EP20080021838 patent/EP2199411B1/en active Active
-
2009
- 2009-12-08 DK DK09771304.4T patent/DK2376648T3/da active
- 2009-12-08 ES ES09771304.4T patent/ES2606350T3/es active Active
- 2009-12-08 WO PCT/EP2009/008764 patent/WO2010069499A2/en not_active Ceased
- 2009-12-08 EP EP09771304.4A patent/EP2376648B1/en active Active
- 2009-12-08 JP JP2011541165A patent/JP2012511917A/ja active Pending
- 2009-12-08 CA CA2747312A patent/CA2747312C/en active Active
- 2009-12-08 PL PL09771304T patent/PL2376648T3/pl unknown
- 2009-12-08 US US13/139,808 patent/US20120107810A1/en not_active Abandoned
Non-Patent Citations (5)
| Title |
|---|
| JPN5012005213; ＦＬＡＮＡＧＡＮ Ｂ Ｆ ｅｔ ａｌ: 'ＤＮＡＳＥ ＨＹＰＥＲＳＥＮＳＩＴＩＶＩＴＹ ＡＮＤ ＭＥＴＨＹＬＡＴＩＯＮ ＯＦ ＴＨＥ ＨＵＭＡＮ ＣＤ３Ｇ ＡＮＤ Ｄ ＧＥＮＥＳ ＤＵＲＩＮＧ Ｔ-ＣＥＬＬ ＤＥＶＥＬＯＰＭＥＮＴ' ＩＭＭＵＮＯＧＥＮＥＴＩＣＳ Ｖｏｌ． ３１, 1990, ｐ． １３-２０, ＳＰＲＩＮＧＥＲ ＶＥＲＬＡＧ * |
| JPN5012005214; ＣＬＥＶＥＲＳ Ｈ ｅｔ ａｌ: ＥＭＢＯ ＪＯＵＲＮＡＬ Ｖｏｌ． ８， Ｎｏ． ９, 1989, ｐ． ２５２７-２５３５ * |
| JPN5012005215; ＴＵＴＴ ＬＡＮＤＯＬＦＩ Ｍ Ｍ ｅｔ ａｌ: 'ＳＰＥＣＩＦＩＣ ＤＥＭＥＴＨＹＬＡＴＩＯＮ ＯＦ ＴＨＥ ＣＤ４ ＧＥＮＥ ＤＵＲＩＮＧ ＣＤ４ Ｔ ＬＹＭＰＨＯＣＹＴＥ ＤＩＦＦＥＲＥＮＴＩＡＴＩＯＮ' ＭＯＬＥＣＵＬＡＲ ＩＭＭＵＮＯＬＯＧＹ Ｖｏｌ． ３４， Ｎｏ． １, 199701, ｐ． ５３-６１ * |
| JPN5012005216; ＬＵＳＳＯ Ｐ ｅｔ ａｌ: ＮＡＴＵＲＥ Ｖｏｌ． ３４９, 19910207, ｐ． ５３３-５３５ * |
| JPN5012005217; ＧＥＯＲＧＯＰＯＵＬＯＳ Ｋ ｅｔ ａｌ: ＴＨＥ ＥＭＢＯ ＪＯＵＲＮＡＬ Ｖｏｌ． ７， Ｎｏ． ８, 1988, ｐ． ２４０１-２４０７ * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016515397A (ja) * | 2013-04-19 | 2016-05-30 | エピオンティス ゲーエムベーハー | 生体サンプルにおける定量的細胞組成を特定する方法 |
| JP2020505938A (ja) * | 2017-02-09 | 2020-02-27 | エピオンティス ゲーエムベーハー | エピジェネティックな免疫細胞計数のための改善された方法 |
| JP2021502061A (ja) * | 2017-10-25 | 2021-01-28 | エピオンティス ゲーエムベーハー | 免疫細胞、特にｐｄ１＋ 細胞の同定のためのエピジェネティックマーカーとしてのｐｄｃｄ１ |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2199411B1 (en) | 2015-05-06 |
| DK2199411T3 (en) | 2015-08-03 |
| CA2747312C (en) | 2018-11-06 |
| EP2376648B1 (en) | 2016-09-14 |
| WO2010069499A3 (en) | 2010-08-26 |
| EP2199411A1 (en) | 2010-06-23 |
| ES2606350T3 (es) | 2017-03-23 |
| WO2010069499A2 (en) | 2010-06-24 |
| HK1163189A1 (zh) | 2012-09-07 |
| CA2747312A1 (en) | 2010-06-24 |
| DK2376648T3 (da) | 2017-01-02 |
| PL2376648T3 (pl) | 2017-05-31 |
| EP2376648A2 (en) | 2011-10-19 |
| US20120107810A1 (en) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511917A (ja) | １型の血液細胞成分の同定のためのエピジェネティックマーカー | |
| US10876163B2 (en) | Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene | |
| JP6224631B2 (ja) | Ｃｄ３ｃｄ４陽性ｔリンパ球の同定用のエピジェネティックマーカー | |
| US9096900B2 (en) | Epigenetic marker for the identification of natural killer cells | |
| JP6543573B2 (ja) | ＣＤ８＋Ｔリンパ球、特にＣＤ８α及びβＴリンパ球の亜集団の同定用のエピジェネティック法 | |
| CA2842266C (en) | Epigenetic marker for the identification of natural killer cells | |
| US12286675B2 (en) | Epigenetic markers for the identification of blood sub-cells of type 1 | |
| US11725243B2 (en) | Epigenetic method for the identification of follicular T-helper-(TFH-) cells | |
| JP2021501574A (ja) | 免疫細胞、特に好塩基性顆粒球の同定のためのエピジェネティックマーカーとしてのｍｃｃ | |
| CA3080060C (en) | Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells | |
| HK1163189B (en) | Epigenetic markers for the identification of cd3 positive t-lymphocytes | |
| CN111278988A (zh) | 作为用于鉴定免疫细胞，特别是初始cd8+ t细胞的表观遗传标志物的内皮唾液酸蛋白(cd248) | |
| EP3669003B1 (en) | Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells | |
| WO2024245828A1 (en) | Itga4 as epigenetic marker for the identification of immune cells | |
| WO2024245668A1 (en) | Crth2 (ptgdr2) as epigenetic marker for the identification of immune cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121101 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121101 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140421 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140707 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140714 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140814 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140821 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140911 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150309 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150723 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160906 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20161007 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161102 |